RSPH Logo Emory Logo
CONTACT . DIRECTORY . SEARCH . HOME

OPUS  . WEBMAIL  . BLACKBOARD  . CALENDAR 
 
 
RESEARCH


ICARE Home
Background
History of Project ICARE
What's New in Project ICARE

Phase V (2005-2007)
Phase IV (2002-2004)
Phase III (1998-2000)
Phase II (1996-1997)
Phase I (1995)

Project ICARE Partners
ICARE Publications
ICARE Abstracts
Contact Us
 


Publications and Book Chapters

Papers in chronological order

2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997

1997

  1. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: the increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-5.

  2. Gaynes RP, Monnet D. The contribution of antibiotic use on the frequency of antibiotic resistance in hospitals. Antibiotic Resistance: Origins, Evolution, Selection, and Spread. Ciba Foundation Symposium 207. J. Wiley and Sons, Chirchester, UK 1997, p 47-60.

  3. Gaynes RP. Antimicrobial resistance. Infect Dis Clin North Am, Vol. 11, No. 4, Dec 1997, p. 757-765.

1998

  1. Monnet D, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr., Gaynes RP, and the Intensive Care Antimicrobial Resistance Epidemiology Project and the National Nosocomial Infections Surveillance System Hospitals. Antimicrobial usage and resistance in eight U.S. hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol 1998; 19,6: 388-94.

  2. McGowan JE Jr., Tenover FC. Antimicrobial resistance in the intensive care unit: Impact of new patterns. Internat J Clin Pract 1998;52(Suppl 95): 14-22.

  3. Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother 1998; 42: 2661-2667. [Paper]

1999

  1. Fridkin SK, Edwards JR, Pichette SC, Pryor ER, Tenover FC, McGowan JE Jr, Culver, DH, Gaynes RP. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis 1999; 28: 1119-25. [Paper]

  2. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr., Archibald LK, Gaynes RP, Tenover FC, and the Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Hospitals. Surveillance of antimicrobial use and antimicrobial resistance in U.S. hospitals: Project ICARE Phase 2. Clin Infect Dis 1999; 29: 245-52. [Paper]

  3. McGowan JE Jr. Drug resistance and nosocomial infections: epidemiology and prevention strategy. In: Balliere's Practice of Infectious Diseases, London, Balliere Tindall 1999;5:177-92.

  4. Fridkin SK, Gaynes RP. Antimicrobial Resistance in Intensive Care Units. Clin Chest Med 1999; 20(2): 303-316.

  5. Lawton RM, Fridkin SK, Stewart CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC Pichette SC, Mohammed J, Felicione E, Hubert S. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, Data Summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System. Amer J Infect Control 1999; 27: 279-84. [Paper]

  6. Steward CD, Stocker SA, Swenson JM, O'Hara CM, Edwards JR, Gaynes RP, McGowan JE Jr., and Tenover FC. Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae. Journal of Clinical Microbiology 1999; 37: 544-547. [Paper]

  7. Hubert SK, Mohammed JM, Fridkin SK, Gaynes RP, McGowan JE Jr., Tenover FC. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method and results of a survey of selected US hospitals. J Clin Microbiol 1999;37:3590-3593.[Paper]

2000

  1. McGowan JE Jr. Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hosp Epidemiol 2000; 21(Suppl): S36-S43.

  2. Lawton RM, Fridkin SK, Gaynes RP, McGowan JE Jr., ICARE Hospitals. Practices to improve antimicrobial use at 47 U.S. hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Infect Control Hosp Epidemiol 2000; 21: 256-259. [Paper]

  3. McGowan JE Jr. The impact of changing pathogens of serious infections in hospitalized patients. Clin Infect Dis 2000; 31(4): S124-S130. [Paper]

  4. Steward CD, Wallace D, Hubert SK, Lawton R, Fridkin SK, Gaynes RP, McGowan JE Jr., Tenover FC. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: A survey of Project ICARE laboratories. Diagn Microbiol Infect Dis 2000; 38: 59-67. [Paper]

2001

  1. McGowan JE Jr. Control of resistance problems in the critical care unit. Antibiotics for Clinicians 2001; 4(Suppl 1): 38-45.

  2. McGowan JE Jr. Year 2000 bugs: the end of the antibiotic era? Proc Roy Coll Med Edinburgh 2001; 31: 17-271.

  3. Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001 33: 324-329. [Paper]

  4. McGowan JE Jr. Increasing threat of Gram-positive bacterial infections in the intensive care unit setting. Crit Care Med 2001; 29(Suppl 4): N69-N74. [Paper]

  5. Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE Jr, ICARE Project, NNIS Hospitals. The effect of vancomycin and third generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med. 2001; 135: 175-183. [Paper]

  6. Fridkin SK. Comparing antibiotic use and resistance data across hospitals. APUA Newsletter 2001; 19(4): 1-3.

  7. Yigit H, Queenan AM, Anderson G, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-1161. [Paper]

  8. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE Jr, Tenover FC. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using NCCLS Extended-spectrum beta-lactamase detection methods. J Clin Microbiol 2001; 39: 2864-2872.[Paper]

2002

  1. Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, McGowan JE Jr, Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002; 8: 697-701. [Paper]

  2. Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP, Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and National Nosocomial Infection Surveillance System (NNIS) Hospitals. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis 2002; 8: 702-707. [Paper]

  3. McGowan JE Jr, Hill HA, Volkova VN, Lawton RM, Haber MJ, Tenover FC, Gaynes RP. Does antimicrobial resistance cluster in individual hospitals? J Infect Dis 2002; 186: 1362-1365. [Paper]

  4. Raney PM, Williams PP, McGowan JE Jr, Tenover FC. Validation of Vitek version 7.01 software for testing staphylococci against vancomycin. Diagn Microbiol Infect Dis 2002; 43: 135-140. [Paper]

  5. Weigel LM, Anderson GJ, Tenover FC. DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis. Antimicrob. Agents Chemother. 2002; 46:2582-2587. [Paper]

  6. Yigit H, Anderson GJ, Biddle JW, Steward CD, Rasheed K, Valera LL, McGowan JE Jr, Tenover FC. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of the OmpF and OmpC porin analogs. Antimicrob Agents Chemother 2002; 46: 3817-3822. [Paper]

  7. Oliver A, Weigel LM, Rasheed JK, McGowan JE Jr, Raney P, Tenover FC. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli. Antimicrob Agents Chemother 2002; 46: 3829-3836.[Paper]

2003

  1. Steward CD, Mohammed JM, Swenson JM, Stocker SA, Williams PP, Gaynes RP, McGowan JE Jr., Tenover FC. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates. J. Clin. Microbiol. 2003;41 351-358.[Paper]

  2. Duck WM, Steward CD, Banerjee SN, McGowan JE Jr, Tenover FC. Optimization of computer settings improves accuracy of pulsed-field gel electrophoresis macrorestriction fragment pattern analysis. J Clin Microbiol 2003; 41: 3035-3042. [Paper]

  3. Tenover FC, Raney PM, Williams PP, Rasheed JK, Biddle JW, Oliver A, Fridkin SK, Jevitt L, McGowan JE Jr. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli using isolates collected during Project ICARE. J Clin Microbiol 2003; 41: 3142-3146. [Paper]

  4. Yigit Y, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, Bush K, Tenover FC. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing ß-lactamase KPC-2. Antimicrob Agents Chemother 2003; 41: 3142-3146[Paper]

  5. Jevitt LA, Smith A, Williams PP, Fridkin SK, Gaynes RP, McGowan JE Jr, Tenover FC. In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microbial Drug Resistance 2003; 9: 383-93.[Paper]

2004

  1. McGowan JE Jr, Tenover FC. Confronting bacterial resistance in healthcare settings – a crucial role for the microbiologist. Nature Reviews Microbiology 2004; 2: 251-258. [Paper]

  2. McGowan JE Jr. Antimicrobial resistance and its relationship to antimicrobial use. Eur J Hosp Pharm 2004; 10: 31-32.

  3. Schwaber MJ, Raney PM, Rasheed JK, Biddle JW, Williams P, McGowan JE Jr, Tenover FC. Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J Clin Microbiol 2004; 42: 294-298.[Paper]

  4. McGowan JE Jr. Minimizing antibiotic resistance – the key role of the infectious diseases physician. Clin Infect Dis 2004; 38: 939-41.[Paper]

  5. McGowan JE Jr. Debate: Guidelines for the control of glycopeptide-resistant enterococci (GRE) have not yet worked. J Hospital Infection 2004; 57: 281-284. [Paper]

2005

  1. Welsh, K.J., Barlow M, Tenover FC, Biddle JW, Rasheed JK, Clark LA, McGowan JE Jr. Experimental prediction of the evolution of ceftazidime resistance in the CTX-M-2 extended-spectrum beta-lactamase. Antimicrob Agents Chemother 2005; 49:1242-1244. [Paper]

  2. Steward CD, Raney PM, Morrell AK, Williams PP, McDougal LK, Jevitt L, McGowan JE Jr, Tenover FC. Testing for induction of clindamycin-resistance in erythromycin-resistant isolates of Staphylococcus aureus. J Clin Microbiol 2005; 43: 1716-1721. [Paper]

2006

  1. Rao AN, Barlow M, Clark LA, Boring JR III, Tenover FC, McGowan JE Jr. Class 1 integrons in resistant Escherichia coli and Klebsiella spp, US hospitals. Emerg Infect Dis 2006; 12: 1012-1014. [Paper]

  2. Raney PM, Tenover FC, Carey RB, McGowan JE Jr, Patel JB. Investigation of inducible clindamycin and telithromycin resistance in isolates of beta-hemolytic streptococci. Diagn Microbiol Infect Dis 2006; 55: 213-218. [Paper]

  3. Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, Rasheed JK, Biddle JW, McGowan JE Jr., Hanna B. Failure of automated susceptibility testing systems to detect carbapenem resistance in Klebsiella pneumoniae mediated by KPC beta-lactamases. Emerg Infect Dis 2006; 1209-1213. [Paper]

  4. Jevitt LA, Thorne GM, Traczewski MM, Jones RN, McGowan JE Jr,
    Tenover FC, Brown SD. Multicenter evaluation of the Etest and disk
    diffusion methods for differentiating daptomycin-susceptible from
    non-daptomycin-susceptible Staphylococcus aureus isolates. J Clin Microbiol 2006; 44: 3098-3104. [Paper]

2007

  1. Stone ND, O’Hara CM, Williams PP, McGowan JE Jr. Tenover FC. Comparison of disk diffusion, VITEK 2, and broth microdilution
    antimicrobial susceptibility testing results for unusual species of Enterobacteriaceae . J Clin Microbiol 2007; 45: 340-346 . [Paper]

  2. Juretschko S, LaBombardi VJ, Lerner SA, Schreckenberger PC, PseudomonasAST Study Group (incl McGowan JE Jr, Tenover FC, Williams PP). Accuracies of Beta-Lactam Susceptibility Test Results for Pseudomonas aeruginosa with Four Automated Systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2. J Clin Microbiol 2007; 45: 1339-1342. [Paper]

  3. Tenover FC, Vaughn RR, McDougal LK, Fosheim GE, McGowan JE Jr. Multiple Locus Variable Number Tandem Repeat Assay Analysis of Methicillin-Resistant Staphylococcus aureus Strains. J Clin Microbiol 2007; 45: 2215-2219. [Paper]

  4. Tenover FC, Williams PP, Stocker S, Thompson A, Clark LA, Limbago B, Carey RB, Poppe SM, Shinabarger D, McGowan JE Jr. Accuracy of six antimicrobial susceptibility methods for testing linezolid against Staphylococci and Enterococci. J Clin Microbiol 2007; 45: 2917-2922. [Paper]

2008

  1. Srinivasan V, McGowan JE Jr, McAllister S, Tenover FC. in vitro activity of ceftobiprole against coagulase-negative staphylococci isolated in the USA. Internat J Antimicrob Agents 2008; 31: 296-298 . [Paper]

    2. Back to top

    PHASE V OF PROJECT ICARE IS SPONSORED IN PART BY:

    AstraZeneca    Elan     J&J PRD     Pfizer     3M Health Care


    © 2007 ICARE, All rights reserved.
    For all problems or questions regarding this website
    please contact Dr. John McGowan at jmcgowa@sph.emory.edu











Home | About RSPH | Academics | Departments | Prospective Students | Current Students | Alumni Site Map | Intranet  






©  Emory University. The Robert W. Woodruff Health Sciences Center.   2008 .  All Rights Reserved.